Erkan Topkan is an expert in Oncology at Baskent universitesi (Turkey). As of October 2026, ScienceLeadR ranks Erkan Topkan in the top 1% of experts worldwide for Sarcopenia, Otorhinolaryngologic Neoplasms and Pharyngeal Diseases. Erkan Topkan has authored 383 publications, the most recent in 2026. SLR score: 1,461 (community average: 125). How the SLR is computed.

LeadR Profile

Erkan Topkan Baskent universitesi Turkey
1 461 ScienceLeadR Reputation 1461
Network Map

Oncology

Subspecialties: Surgery - Radiotherapy - Otolaryngology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026

Source: PubMed

Baskent universitesi

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 383

Citations

Citations: 1 705 1st author: 188 Last author: 73 Unique author: 7


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Dose-Informed Surgical Margin in Mandibular Osteoradionecrosis Surgery: Integrating Radiation Biology into Osteotomy Planning.
PMID 42930379 — radiotherapy, margins of excision, osteotomy, hemorrhage, osteoradionecrosis, mandibular injuries, radiobiology, necrosis, mandibular reconstruction
Clin Pract20260
Tooth Extraction Timing After Head and Neck Radiotherapy: A Critical Reappraisal of Osteoradionecrosis Risk and Biological Vulnerability.
PMID 42931359 — radiotherapy, tooth, osteoradionecrosis, selection bias, tooth extraction, radiation exposure
Methods Protoc20260
Dental Implants After Head and Neck Radiotherapy: From Chronological Waiting Rules to Implant-Bed-Specific Risk Stratification.
PMID 42793429 — radiotherapy, dental implants, neoplasms, rehabilitation, head and neck neoplasms
Healthcare (Basel)20260
Comment on "The Prognostic Significance of Sarcopenia Assessed by the Psoas Muscle Index in Multiple Myeloma patients.".
PMID 42712698 — muscles, psoas muscles, multiple myeloma, sarcopenia
Indian J Hematol Blood Transfus20260
The Host Tissue Repair Vulnerability Index (HTRVI): A Composite Biomarker for Predicting Osteoradionecrosis in Locally Advanced Nasopharyngeal Carcinoma.
PMID 42646561 — radiotherapy, hemoglobins, osteoradionecrosis, biomarkers, nasopharyngeal carcinoma, tissues
Med Sci (Basel)20260

LeadR Networks

Main global connection map